Global Buprenorphine Hydrochloride Market Growth 2023-2029

Global Buprenorphine Hydrochloride Market Growth 2023-2029

Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.

LPI (LP Information)' newest research report, the “Buprenorphine Hydrochloride Industry Forecast” looks at past sales and reviews total world Buprenorphine Hydrochloride sales in 2022, providing a comprehensive analysis by region and market sector of projected Buprenorphine Hydrochloride sales for 2023 through 2029. With Buprenorphine Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Buprenorphine Hydrochloride industry.

This Insight Report provides a comprehensive analysis of the global Buprenorphine Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Buprenorphine Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Buprenorphine Hydrochloride market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Buprenorphine Hydrochloride and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Buprenorphine Hydrochloride.

The global Buprenorphine Hydrochloride market size is projected to grow from US$ 135.5 million in 2022 to US$ 155.3 million in 2029; it is expected to grow at a CAGR of 155.3 from 2023 to 2029.

Europe is the largest market with about 31% market share. Middle East& Africa and Asia-Pacific are follower.

The main manufacturers are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, Micro Orgo Chem, Faranshimi etc. Siegfried is the largest manufacturer with about 23% market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Buprenorphine Hydrochloride market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Tablets
Injection

Segmentation by application
Analgesic
Opioid Antagonist

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi

Key Questions Addressed in this Report

What is the 10-year outlook for the global Buprenorphine Hydrochloride market?

What factors are driving Buprenorphine Hydrochloride market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Buprenorphine Hydrochloride market opportunities vary by end market size?

How does Buprenorphine Hydrochloride break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.